InvestorsHub Logo
Followers 74
Posts 16338
Boards Moderated 3
Alias Born 04/24/2000

Re: Theo post# 1967

Thursday, 12/13/2018 8:26:57 AM

Thursday, December 13, 2018 8:26:57 AM

Post# of 2104
This, however, I was NOT aware of. Very bullish imo:

"One of Conatus’s biggest assets is financial backing from Novartis Pharmaceuticals(Nasdaq: NVS). A large bioscience company does not throw out money without conducting proper due diligence. On December 5th, the same day the data came out, Conatus converted a promissory note granted to Novartis 2,882,519 shares in exchange for $15 million. If you do the math that comes out to around $5.2 per share."

Theo ;-)